Paris-based ProductLife Group, a provider of regulatory, vigilance and quality services for the pharmaceutical, medtech and biotech sectors, announced that it has acquired Dutch-based Zwiers Regulatory Consultancy.
The Dutch company is a consultancy that specialises in regulatory affairs, pharmacovigilance, and integrated development for drugs and devices with offices in Amsterdam and Oss (Netherlands).
Providing full regulatory support
Founded in September 2011, Zwiers Regulatory Consultancy offers full regulatory support, throughout the entire drug lifecycle. From initial clinical trial application to post-marketing compliance.
In order to assure compliance throughout the product life cycle, it provides product development services in the EU, the US, and other countries. These services encompass early and late-stage strategic and regulatory assistance up to dossier submission and beyond. Its services include strategic advice, writing, creating, reviewing, and compiling regulatory and pharmacovigilance documents and eCTDs, as well as regulatory intelligence and training.